X4 Pharmaceuticals at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
X4 Pharmaceuticals at ASH 2026 in New Orleans: Booth 2213.
| Organization | ASH 2026 Attendance |
|---|---|
X4 Pharmaceuticals Boston, MA | |
Rare-disease biotech developing CXCR4-targeted therapies; its approved drug mavorixafor (Xolremdi) is being studied in chronic neutropenia. | Booth Exhibiting at Booth 2213 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Find decision makers at X4 Pharmaceuticals
Tell us what you sell and we’ll find the people at X4 Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction